News - Page 7 of 13 - Xtant Medical

Xtant Medical Announces Debt Restructuring

August 10, 2020

BELGRADE, Mont., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has entered into a Restructuring and Exchange Agreement with the

Xtant Medical Announces Second Quarter 2020 Financial Results

August 3, 2020

BELGRADE, Mont. , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2020

Xtant Medical to Issue Second Quarter 2020 Financial Results on August 3, 2020

July 30, 2020

BELGRADE, Mont. , July 30, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended

Xtant Medical Announces First Quarter 2020 Financial Results

May 7, 2020

BELGRADE, Mont. , May 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2020 .

Xtant Medical to Issue First Quarter 2020 Financial Results on May 7, 2020

April 30, 2020

BELGRADE, Mont. , April 30, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended

Xtant Medical Announces Fourth Quarter and Full Year 2019 Financial Results

March 5, 2020

BELGRADE, Mont. , March 05, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended

Xtant Medical to Issue Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 5, 2020

February 27, 2020

BELGRADE, Mont. , Feb. 27, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full

Xtant Medical Announces Third Quarter 2019 Financial Results

November 7, 2019

BELGRADE, Mont. , Nov. 07, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30,

Xtant Medical to Issue Third Quarter 2019 Financial Results on November 7, 2019

November 4, 2019

BELGRADE, Mont. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended

Xtant Medical to Feature Innovative Product Offering at the CNS Annual Meeting

October 18, 2019

BELGRADE, Mont. , Oct. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, will feature its recently announced Intice™-C Titanium Cervical Interbody Spacer, Atrix-C

Xtant Medical Names Sean Browne President and Chief Executive Officer

October 7, 2019

BELGRADE, Mont. , Oct. 07, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Sean Browne as President and Chief Executive Officer,

Xtant Medical Showcases Continued Innovation with Three New Product Introductions at NASS 2019

September 18, 2019

BELGRADE, Mont., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, plans to introduce three new products at the North American Spine Society (NASS) 2019